Cannabinoids activate the firing of mesoprefrontocortical dopamine neurons
and release dopamine in the prefrontal cortex. This study was undertaken wi
th the aim of clarifying the interaction between cannabinoids and mesocorti
cal system in the prefrontal cortex. The effect of Delta (9)-tetrahydrocann
abinol (Delta (9)-THC) and the synthetic CB1 agonist WIN55,212-2 (WIN) was
studied by extracellular single unit recordings, in chloral hydrate anaesth
etised rats, on the spontaneous activity of pyramidal neurons and on the in
hibition produced on these neurons by the electrical stimulation of the ven
tral tegmental area (VTA). Intravenously administered Delta (9)-THC and WIN
(1.0 and 0.5 mg/kg, respectively), increased the firing rate of pyramidal
neurons projecting to the VTA. VTA stimulation produced a phasic inhibition
(167 +/- 6 ms) in 79% of prefrontal cortex pyramidal neurons. Delta (9)-TH
C and WIN reverted this inhibition in 73% and 100% of the neurons tested, r
espectively. The subsequent administration of the selective CB1 antagonist
SR141716A (1 mg/kg) readily suppressed the effects of both cannabinoids and
restored the inhibitory response to VTA stimulation. Moreover, when admini
stered alone, SR141716A prolonged the inhibition in 55.6% of the neurons te
sted. The results indicate that stimulation of CB1 receptors by cannabinoid
s results in an enhanced excitability of prefrontal cortex pyramidal neuron
s as indexed by the suppression of the inhibitory effect of VTA stimulation
and by the increase in firing rate of antidromically identified neurons pr
ojecting to the VTA. Furthermore, our results support the view that endogen
ous cannabinoids exert a negative control on dopamine activity in the prefr
ontal cortex. This study may be relevant in helping to understand the influ
ence of cannabinoids on cognitive processes mediated by the prefrontal cort
ex.